EV/EBITDA Multiple: Rezolute Corp (RZLT)
Rezolute, Inc. (RZLT) growth is constrained by a lack of commercial scaling due to high R&D costs, as reflected in the EV/EBITDA chart with historical data, where the value remains at 0.00. The business foundation consists of strict FDA oversight and patent protection, while a strong reputation among physicians confirms its status as an innovator in the treatment of rare metabolic pathologies.
rezolutebio.com (RZLT) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
- net income and valuation multiples indicators:
RZLT - Net Financial Result|Expected Profit Rezolute, Inc.|RZLT - Price to Earnings Ratio|Future Price to Earnings Rezolute, Inc.|RZLT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Rezolute Bio|RZLT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Rezolute|RZLT - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months rezolutebio.com|RZLT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Rezolute, Inc.
Initial company analysis:RZLT (Rezolute Corp)
To minimize risks when selecting an issuer, it is essential to filter out market noise and assess the real value of assets relative to their yield. By analyzing the EV/EBITDA multiple, which relates the total enterprise value—including debt and taxes—to operating profit, an investor in Rezolute, Inc. (RZLT) can determine a fair entry price before the company potentially implements monopoly pricing within the rare disease niche.
Who Rezolute, Inc. competes with
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ascendis Pharma Inc. ASND|MDGL - Enterprise Value to EBITDA Ratio|Corcept Therapeutics - EV/EBITDA Multiple|Company Value to EBITDA rhythmtx.com|AKRO (Akero) - Enterprise Value to EBITDA Ratio|MTSR: Enterprise Value to Operating Income Before Depreciation Ratio|MLTX (MoonLake Pharma) - EV/EBITDA Multiple|EV/EBITDA Multiple Crinetics Corp|EV/EBITDA Multiple NAMS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SLNO (soleno.life)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Company Value to EBITDA|AGIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GPCR: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDXG: EV/EBITDA Multiple|LXRX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MBX Biosciences|Altimmune Inc (ALT) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aardvark Therapeutics Corp (AARD)|Enterprise Value to EBITDA Ratio Sagimet Biosciences Inc SGMT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BioAge Labs, Inc. BIOA|Business Value to Operating Income Before Depreciation BMEA|Quince - EV/EBITDA Multiple|Company Value to EBITDA Fractyl Health Inc.|VTVT (vtvtherapeutics.com) - Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio ATPC (Agape ATP)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pluristem Therapeutics|Company Value to EBITDA Synlogic Corp SYBX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lipocine (LPCN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MTNB (matinasbiopharma.com)|Spruce Biosciences - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Galecto Corporation GLTO|CTCX: Enterprise Value to EBITDA Ratio|lumos-pharma.com - Enterprise Value to Operating Income Before Depreciation Ratio|ONVO: EV/EBITDA Multiple|Company Value to EBITDA Radius Recycling Inc. (RDUS)
